MedPath

Cefazolin

Cefazolin for Injection, USP

Approved
Approval ID

d24529e3-e2b4-46d6-81ba-b7da74501792

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 1, 2022

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefazolin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71205-679
Application NumberANDA203661
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateAugust 1, 2022
FDA Product Classification

INGREDIENTS (1)

Cefazolin SodiumActive
Quantity: 1 g in 1 1
Code: P380M0454Z
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefazolin - FDA Drug Approval Details